by Jay Nanduri | Aug 30, 2024 | Technology
Continuing with my series on AI, today I want to discuss the following question: How to make healthcare data available for clinical and life science research while leveraging AI in a safe and compliant manner? There are four aspects to compliance in healthcare...
by Truveta staff | Aug 15, 2024 | Technology
Psoriasis is more than just a skin condition – it’s a chronic, systemic disease that affects over 8 million people in the United States, profoundly impacting their quality of life. As a complex, immune-mediated disease, psoriasis presents a variety of challenges to...
by Truveta staff | Jul 30, 2024 | Technology
By the time most women with ovarian cancer are diagnosed, 70-80% are already at an advanced stage of the disease. Despite declining mortality rates over the past decade, the 5-year survival rate for patients with ovarian cancer remains less than 30%. Sometimes...
by Jay Nanduri | Jul 30, 2024 | Technology
In this blog I will discuss our approach to scaling our AI technologies across multiple dimensions while controlling development costs, operational costs, and assuring stability. LLMs are a powerful new technology, but they also have large development, operational,...
by Jay Nanduri | Jul 1, 2024 | Technology
In this post, I would like to discuss the way we addressed the following challenge: How to ensure that the AI technologies used in our platform have requisite accuracy and explainability while assuring fairness and avoidance of bias Healthcare and life science...
by Truveta staff | Jun 17, 2024 | Data, News, Technology
Truveta now offers regulatory and audit capabilities to support our customers for real-world evidence (RWE) submissions to the Food and Drug Administration (FDA) and other global regulatory authority decisions. These regulatory grade capabilities advance Truveta’s...
